Quick Takeaways
- David Charles Lubner has 7 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
Insider Trading & Ownership of David Charles Lubner
- Location
- Watertown, MA
- Signature
- /s/ Michelle Gilson, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David Charles Lubner and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Arcellx, Inc. ($0).
- Past-year value change for that position: -$450,000.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of David Charles Lubner
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ACLX | Arcellx, Inc. | Director | $0 | -$450,000 | -100% | 28 Apr 2026 |
| DYN | Dyne Therapeutics, Inc. | Director | $0 | 24 Apr 2026 | ||
| CRGX | CARGO Therapeutics, Inc. | Director | 19 Aug 2025 | |||
| IRON | Gemini Therapeutics, Inc. /DE | Director | 04 Oct 2021 | |||
| CBIO | GLYCOMIMETICS INC | Director | 23 Jun 2025 | |||
| PNT | POINT Biopharma Global Inc. | Director | 26 Dec 2023 | |||
| VOR | Vor Biopharma Inc. | Director | 22 May 2025 |
Insider Transactions Reported by David Charles Lubner:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.